Clinical trial
Investigation of Pain Incidence After FK506 Immunosuppressive Therapy in Liver Transplantation Patients
NCT04559048 is registered in ClinicalTrials.gov with The Second Hospital of Tangshan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation of Pain Incidence After FK506 Immunosuppressive Therapy in Liver Transplantation Patients
- Lead sponsor
- The Second Hospital of Tangshan
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 15, 2019
- Completion date
- June 30, 2024
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic pain, liver transplantation